Thailand: a new therapeutic opportunity for patients with bladder cancer.

Thailand: a new therapeutic opportunity for patients with bladder cancer.

Thai FDA yesterday approved Physioner mini 30, EMDA (Electro Motive Drug Administration)
EMDA has been developed for the treatment of superficial bladder tumours. It improves the efficacy of the drug which is administered in your bladder and that is to prevent cancer.

EMDA stands for Electro Motive Drug Administration and it is based on the ancient iontophorese technique which facilitates the transportation of certain drugs deeper into the body, by means of an electrical potential difference.

Iontophoresis is a non-invasive means of administering medical drugs by using electrically charged medication-containing particles (ions).

The Device is produced in Italy by PHYSION Srl and distributed in Thailand by Kha Bangkok Co., Ltd. (KHA GROUP)